• Top 10 Stories of 2019: National Genomic Data Initiatives, AI’s Impact in Drug Development, And More

    Bio-IT World | As we head into 2020, we at Bio-IT World would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2019, ranked in order of popularity.

    Jan 9, 2020
  • How To Improve Biopharmaceutical Research Data Utilization?

    Bio-IT World Contributed Commentary | Many enterprise network security people intuitively put everything behind a firewall—even though it has been well-established that firewalls are big hindrance to high-speed data flows. There are a few reasons of poor data mobility and thus low utilization.

    Jan 8, 2020
  • Follow the Money: New Life Sciences Investment Firm, Funding for Deep Genomics, Verantos, TwinStrand Biosciences, More

    Bio-IT World  Perceptive Advisors launches a new venture capital fund for early-stage life sciences companies. Deep Genomics closes its series B round to fund its AI-powered drug discovery platform. Several molecular diagnostics companies receive funding to advance PCR platforms and companion diagnostics. TwinStrand Biosciences closes a Series A fund to create a new genomic sequencing technology, and more.

    Jan 7, 2020
  • Heart-In-A-Jar Platform Humanizing Preclinical Research

    Bio-IT World | Stem cell biotech company Novoheart has been bioengineering miniature human hearts as a platform for drug discovery and development for several to pharmaceutical firms, notably for human conditions without a good animal model for preclinical testing. Novoheart’s thumb-sized human “heart-in-a-jar” models can both contract and eject blood-like fluid, making it possible to measure how well the heart is pumping.

    Jan 6, 2020
  • Keeping It Real: Challenges And Benefits Of Integrating AI And Machine Learning Into Pharma R&D

    Bio-IT World Contributed Commentary | Productivity in the pharmaceutical industry is rapidly declining. This crisis has created a need to re-think the way clinical trials are conceived, designed and conducted. As such, artificial intelligence is poised to transform the industry.

    Jan 3, 2020
  • Illumina, PacBio Terminate Merger Agreement

    Bio-IT World | Illumina and Pacific Biosciences of California today announced that they have mutually agreed to terminate their merger agreement. In accordance with the merger agreement, Illumina will pay Pacific Biosciences a termination fee of $98 million.

    Jan 2, 2020
  • 2020 Bio-IT Predictions: Digital Transformation Creates Opportunity and Obstacles

    Bio-IT World Contributed Commentary | They say change is good, but it’s best if you have the ability to adapt. That’s certainly the case in the IT space, where digital transformation continues to drive rapid advancement across virtually every industry, and certainly in the life sciences. Here are some predictions and potential challenges to consider heading into next year.

    Jan 2, 2020
  • Caris, GenScript, Fuzionaire, and More: News From December 2019

    Bio-IT World | December featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Caris, GenScript, Fuzionaire, and more.

    Dec 23, 2019
  • A Digital Transformation at the City of Hope

    Bio-IT World | City of Hope National Medical Center’s Chief Digital Officer discusses his role at City of Hope, the changing point-of-care landscape, and future digital transformations for the industry.

    Dec 19, 2019
  • A Regulatory View of Personalized Therapeutics

    Bio-IT World | The FDA’s Director of the Center for Biologics Evaluation and Research discusses the obstacles in developing gene therapies, emerging developments in the field, and the regulatory landscape surrounding personalized therapeutics.

    Dec 18, 2019
  • BioIVT Announces the Launch of its Next-generation Sequencing Service

    Bio-IT World News Brief | BioIVT today launched its Next-generation Sequencing (NGS) Service, which combines the company’s expertise in human tissue procurement, specimen selection, sample preparation and project management with its in-house NGS capabilities.

    Dec 16, 2019
  • Identifying Opportunities At The Interface Of Life Sciences And Tech

    Bio-IT World | Geraldine A. Van der Auwera calls herself a benevolent dictator. She boasts the pedigree of pre-doctoral and postdoctoral years in microbiology labs, and then a shift into computation. Now, as Director of Outreach and Communications, Data Sciences Platform, at the Broad Institute, she works with all camps—scientists, biomedical researchers, data scientists, technologists.

    Dec 16, 2019
  • An AI-Based Evolution of Clinical Communities

    Bio-IT World | AI can bring efficacious, precise, and effective diagnostics and therapeutics faster to the patient, and in the future, more efficient operations could save money, freeing up capital to invest in innovation.

    Dec 13, 2019
  • Has Validation In An Agile Software Development Environment Come Of Age?

    Bio-IT World Contributed Commentary | Today it is accepted that agile software development can work well within a formal project and most software vendors supplying the pharmaceutical industry have an agile aspect to their Software Development Life Cycle (SDLC).

    Dec 12, 2019
  • Precision Medicine: Setting a Strong Foundation to Accelerate Progress

    Bio-IT World Contributed Commentary | Precision medicine depends on data—more specifically, on our ability to analyze and act on it from the bench to the bedside and back again. And, we’ve long understood that our ability to direct data—both structured and unstructured—when and where it’s most needed is foundational to advancing and unlocking the promise of precision medicine.

    Dec 11, 2019
  • Clockwork: Scientists Tinker with the Inner Workings of Circadian Rhythm

    Bio-IT World | The human clock is increasingly being thrown off-kilter by our modern lifestyles—TVs in bedrooms, electronic books in bed, smartphones sitting on nightstands. These types of technologies, and other disruptors like jet lag or third shift work, can wreak havoc on our bodily rhythm and, along with it, bodily processes. Circadian dysfunction has been linked to a higher risk of health issues like obesity, diabetes, and certain forms of cancer. Enter circadian rhythm research.

    Dec 9, 2019
  • Asia-wide Genome Mapping Project Reveals Insights Into Asian Ancestry, Genetic Diversity

    Bio-IT World News Brief | In their first study reported in Nature this week, the GenomeAsia 100K consortium analyzed the genomes of 1,739 people, which represents the widest coverage of genetic diversity in Asia to date.

    Dec 6, 2019
  • To Advance Polygenic Risk Scores, Large Studies Need Better Genotyping Tools

    Bio-IT World Contributed Commentary | A decade ago, the concept of a polygenic risk score had not even been cited in a genomics publication. Today, it’s almost impossible to pick up a human genetics journal or attend a conference without hearing about these new biomarkers.

    Dec 5, 2019
  • The Nose Knows: Developing Artificial Intelligence Sniffers

    Bio-IT World | When you think of artificial intelligence, what comes to mind? A computer brain? Computer vision? Auditory language processing? What about smell? It’s an area of research IBM is busy exploring.

    Dec 4, 2019
  • Benchling: Enabling the Next Generation of Data and Workflow Tracking

    Bio-IT World Benchling’s value proposition is easy to see. For researchers—whether in an academic lab, small biotech, or big pharma—keeping track of research using paper lab notebooks, email, and spreadsheets is cumbersome and inefficient. But the challenges to science are much bigger than just misplaced notes or forgotten results. The real value, says Saji Wickramasekara, comes from enabling a new level of collaboration and data provenance.

    Dec 2, 2019